drugset / Trial / NCT03733587
GX-I7 With Cyclophosphamide in Patients With Metastatic or Recurrent Solid Tumors
SequentialOpen-labelTreatment
Summary
This is a Phase 1b study to explore the safety and efficacy of GX-I7 in combination with CPA in patients with metastatic or recurrent solid tumors.
Timeline
- Start
- 2018-10-17
- Primary completion
- 2020-04-02
- Completion
- 2020-05-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NT-I7 | Protein / enzyme biologic | — | — |
| Background | Cyclophosphamide | Other / unclassified | — | — |